<?xml version="1.0" encoding="UTF-8"?>
<p id="p0065">The people most affected by SARS-CoV-2 infection are adults aged &gt;60Â years with one or more concomitant medical conditions such as cardiovascular, hepatic, renal and/or bone marrow co-morbidities. Neutropenia, hepatitis, increased hepatic enzymes, QT prolongation, and bone marrow dysfunction are possible COVID-19 manifestations and potential adverse events of chloroquine, hydroxychloroquine, Tocilizumab, Sarilumab, and anti-IL-1 agents [
 <xref rid="bb0010" ref-type="bibr">2</xref>]. Steroids, and anti-IL-6 and anti-IL-1 agents may lead to profound immunosuppression and increase the risk of infections, and anti-IL-6 agents have also been associated with bacterial pneumonia and gastrointestinal perforation [
 <xref rid="bb0050" ref-type="bibr">[10]</xref>, 
 <xref rid="bb0055" ref-type="bibr">[11]</xref>, 
 <xref rid="bb0060" ref-type="bibr">[12]</xref>, 
 <xref rid="bb0065" ref-type="bibr">[13]</xref>, 
 <xref rid="bb0070" ref-type="bibr">[14]</xref>, 
 <xref rid="bb0075" ref-type="bibr">[15]</xref>, 
 <xref rid="bb0080" ref-type="bibr">[16]</xref>].
</p>
